CHRONIC ERYTHEMA NODOSUM AS A SIGN OF TUBERCULOSIS INFECTION
DOI:
https://doi.org/10.66344/jpad.32.3.2022.1965Abstract
Abstract Introduction: Erythema nodosum (EN) is a subcutaneous fat tissue inflammation (panicullitis) characterized by diffuse erythematous nodules symmetrically distributed in the anterior part of the lower extremities. EN is considered as a reactive process which can be triggered by a wide variety of factors including mycobacterium (M.) tuberculosis infection. Case: A 21-year-old woman, presented in our department with a 9-month-history of painful erythematous nodules on both legs accompanied by ankle swelling and joint pain. Previous treatments with amoxicillin-clavulanic acid, steroid, and nonsteroidal anti-inflammatory drug (NSAID) did not yield satisfactory results. On examination, we found multiple tender erythematous nodules symmetrically distributed on both legs. On laboratory examination, C-reactive protein and erythrocyte sedimentation rate were increased, interferon-gamma release assay (IGRA) test was found positive for M. tuberculosis infection. The patient was treated with standard anti-tuberculosis regimen and hexagonal water without additional steroids or other immunosupressive drugs. Clinical resolution was gradually achieved and by the third month of therapy only minimal post-inflammatory hyperpigmentation lesions remained. Discussion: EN is a self-limiting disease but in certain cases can be chronic and refractory. Identification and elimination of underlying causes of EN are essential to achieve satisfying results. Conclusion: We reported a case of EN with positive IGRA result for M. tuberculosis infection which was successfully treated with anti-tuberculosis regimen. Keywords: erythema nodosum, mycobacterium tuberculosis, interferon gamma release assay, anti-tuberculosis drugsDownloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.